Yale study identifies racial and ethnic disparities in Oncotype DX testing for women with breast cancer
Can't see this email? View it online
   
  March 20, 2017  
  Breast Cancer  
  The latest breast cancer news from News Medical  
 Yale study identifies racial and ethnic disparities in Oncotype DX testing for women with breast cancerYale study identifies racial and ethnic disparities in Oncotype DX testing for women with breast cancer
 
In a simple definition, cancer is a disease of the cells, which is caused by gene mutations. For a proportion of patients, including women with hormone receptor positive (HR+) breast cancer, gene expression profiling has a substantial impact on treatment decision-making by determining which patients might—or might not—respond to particular treatment options.
 
 
 Mayo study provides vital information on tumor sequencing in newly diagnosed breast cancer patientsMayo study provides vital information on tumor sequencing in newly diagnosed breast cancer patients
 
Tumor sequencing is increasingly used to select treatment for patients with cancer, but its role in women with newly diagnosed breast cancer is unknown.
 
   Shorter radiation treatment for breast cancer patients could reduce health care spendingShorter radiation treatment for breast cancer patients could reduce health care spending
 
More than half of older women with early stage breast cancer received more radiation therapy than what might be medically necessary, adding additional treatment and health care costs, according to a study led by Duke Cancer Institute researchers.
 
   New UCR study may hold answers to achieving better marital qualityNew UCR study may hold answers to achieving better marital quality
 
Achieving marital quality could seem daunting, even impossible to any couple, let alone a couple in which one of the partners is dealing with a serious illness. But a new study by Megan Robbins, psychology professor at the University of California, Riverside, may hold the answer.
 
   Study uncovers genetic link to aggressive form of prostate cancerStudy uncovers genetic link to aggressive form of prostate cancer
 
An international study published in the Journal of the National Cancer Institute has identified a genetic connection to the aggressive form of prostate cancer.
 
 Hair loss prevention device for breast cancer patients showcased by Paxman at Vienna conference
 
Hair loss prevention device for breast cancer patients showcased by Paxman at Vienna conferenceA pioneering scalp cooling treatment that prevents alopecia in early stage breast cancer patients undergoing chemotherapy will be showcased at the 15th St. Gallen International Breast Cancer Conference, Vienna.
 
 
 TSRI researchers develop novel drug delivery method for treating cancers
 
TSRI researchers develop novel drug delivery method for treating cancersScientists from the Florida campus of The Scripps Research Institute have developed a new drug delivery method that produces strong results in treating cancers in animal models, including some hard-to-treat solid and liquid tumors.
 
 
 Evolution of immuno-oncology
 
Evolution of immuno-oncologyImmuno-oncology did not exist four years ago, it's a term coined by Dr. Axel Hoos, Head of the newly defined immuno-oncology department at GSK. He is also Senior Vice President Therapeutic Area (TA) and Head for Oncology R&D. Previously, it was referred to as cancer immunotherapy, but now it is called immuno-oncology (IO).